Literature DB >> 25863561

A pill a day keeps HCV away.

Ivan Gentile1, Guglielmo Borgia2.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25863561     DOI： 10.1016/S1473-3099(15)70127-1

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  4 in total

1.  Direct-acting antivirals improve endothelial function in patients with chronic hepatitis: a prospective cohort study.

Authors:  Matteo Nicola Dario Di Minno; Pasquale Ambrosino; Antonio Riccardo Buonomo; Biagio Pinchera; Ilenia Calcaterra; Manuel Crispo; Riccardo Scotto; Francesco Borgia; Consalvo Mattia; Ivan Gentile
Journal:  Intern Emerg Med       Date:  2019-08-08       Impact factor: 3.397

2.  Direct acting antiviral agents and hepatocellular carcinoma development: don't take it for granted.

Authors:  Antonio Riccardo Buonomo; Ivan Gentile; Guglielmo Borgia
Journal:  Transl Gastroenterol Hepatol       Date:  2017-12-06

3.  The role of curcumin in liver diseases.

Authors:  Antonio Riccardo Buonomo; Riccardo Scotto; Salvatore Nappa; Michele Arcopinto; Andrea Salzano; Alberto Maria Marra; Roberta D'Assante; Emanuela Zappulo; Guglielmo Borgia; Ivan Gentile
Journal:  Arch Med Sci       Date:  2018-02-20       Impact factor: 3.318

4.  Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrence: Results from an Italian real-life cohort (LINA cohort).

Authors:  Antonio Riccardo Buonomo; Riccardo Scotto; Carmine Coppola; Biagio Pinchera; Giulio Viceconte; Costanza Maria Rapillo; Laura Staiano; Mariarosaria Saturnino; Ferdinando Scarano; Federica Portunato; Mariantonietta Pisaturo; Stefania De Pascalis; Salvatore Martini; Grazia Tosone; Salvatore Nappa; Nicola Coppola; Ivan Gentile
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.